Vitrolife AB (publ) (FRA:VTFN)

Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of EUR 1.15 billion. The enterprise value is 1.22 billion.

Market Cap	1.15B
Enterprise Value	1.22B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	135.42M
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	75.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	19.91
PS Ratio	3.62
PB Ratio	1.58
P/TBV Ratio	n/a
P/FCF Ratio	34.09
P/OCF Ratio	19.59
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.78, with an EV/FCF ratio of 36.30.

EV / Earnings	-2.64
EV / Sales	3.80
EV / EBITDA	13.78
EV / EBIT	n/a
EV / FCF	36.30

Financial Position

The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.20.

Current Ratio	3.40
Quick Ratio	2.61
Debt / Equity	0.20
Debt / EBITDA	1.69
Debt / FCF	4.40
Interest Coverage	-94.80

Financial Efficiency

Return on equity (ROE) is -46.55% and return on invested capital (ROIC) is -42.26%.

Return on Equity (ROE)	-46.55%
Return on Assets (ROA)	-21.15%
Return on Invested Capital (ROIC)	-42.26%
Return on Capital Employed (ROCE)	-46.01%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	276,165
Profits Per Employee	-402,366
Employee Count	1,151
Asset Turnover	0.24
Inventory Turnover	3.46

Taxes

In the past 12 months, Vitrolife AB has paid 11.74 million in taxes.

Income Tax	11.74M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-55.71%
50-Day Moving Average	10.92
200-Day Moving Average	12.24
Relative Strength Index (RSI)	27.14
Average Volume (20 Days)	25

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of EUR 317.87 million and -463.12 million in losses. Loss per share was -3.42.

Revenue	317.87M
Gross Profit	184.53M
Operating Income	-446.77M
Pretax Income	-451.39M
Net Income	-463.12M
EBITDA	87.69M
EBIT	-446.77M
Loss Per Share	-3.42

Balance Sheet

The company has 74.75 million in cash and 148.31 million in debt, with a net cash position of -73.55 million.

Cash & Cash Equivalents	74.75M
Total Debt	148.31M
Net Cash	-73.55M
Net Cash Per Share	n/a
Equity (Book Value)	729.52M
Book Value Per Share	5.39
Working Capital	136.48M

Cash Flow

In the last 12 months, operating cash flow was 58.68 million and capital expenditures -24.95 million, giving a free cash flow of 33.73 million.

Operating Cash Flow	58.68M
Capital Expenditures	-24.95M
Free Cash Flow	33.73M
FCF Per Share	n/a

Margins

Gross margin is 58.05%, with operating and profit margins of -140.55% and -145.70%.

Gross Margin	58.05%
Operating Margin	-140.55%
Pretax Margin	-142.01%
Profit Margin	-145.70%
EBITDA Margin	27.59%
EBIT Margin	-140.55%
FCF Margin	10.61%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.21%.

Dividend Per Share	0.10
Dividend Yield	1.21%
Dividend Growth (YoY)	17.20%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	0.07%
Shareholder Yield	1.29%
Earnings Yield	-40.28%
FCF Yield	2.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 2.13 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.13
Piotroski F-Score	5